Senokot-s Tablet
FDA Label NDC 67618-310

1 label section · Submitted to the FDA by Atlantis Consumer Healthcare, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Atlantis Consumer Healthcare, Inc. for the product Senokot-s (NDC 67618-310). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

Senokot-S 60 Tablets Label
NDC: 67618-310-60

60 Tablets Label (Label60)

60 Tablets Label (Label60)

Senokot-S 60 Tablets Leaflet
NDC: 67618-310-60

60 Tablets Leaflet (Leaflet60)

60 Tablets Leaflet (Leaflet60)

Senokot-S 60 Tablets Carton
NDC: 67618-310-60

60 Tablets Carton (Carton60)

60 Tablets Carton (Carton60)

Senokot-S 10 Tablets Carton
NDC: 67618-310-01

10 Tablets Carton Front (Carton10front)

10 Tablets Carton Front (Carton10front)

10 Tablets Carton Back (Carton10back)

10 Tablets Carton Back (Carton10back)

Senokot-S 100 Tablets Label
NDC: 67618-310-10

100 Tablets Label (Bottle100front)

100 Tablets Label (Bottle100front)

Senokot-S 100 Tablets Leaflet
NDC: 67618-310-10

100 Tablets Leaflet (Bottle100back)

100 Tablets Leaflet (Bottle100back)

* Please review the disclaimer below.